opioid dependence

Payers strategize to manage opioid useHow managed care organizations manage opioid utilization and some of the limitations to those management strategies was a hot topic at the AMCP Annual Meeting.
Top strategies for incorporating PDMP data into physician work flowHow can physicians, already struggling to keep up with mounting regulations and larger patient loads, use PDMPs in more effective and efficient ways?
How data analytics combats the opioid epidemicDeaths due to opioid abuse have risen sharply—and show no signs of leveling off. Here’s how data analytics can prevent abuse and diversion.
Opinion: Hospital formularies can play key role in reducing opioid epidemicAdding non-opioid postsurgical options to hospital formularies should be a top consideration.
Study: Use of short-acting opioids decrease, long-acting opioids increaseExecutives need to increase awareness in the category and ensure prescribers are aware of CDC guidelines for opioid prescribing and the prescription drug monitoring programs.
Five ways you can help fight the opioid epidemicThe opioid crisis in the U.S. is a multidimensional problem requiring a multistakeholder solution.
Treatment of opioid use disorderAs problems with opioid use and abuse in the United States increasingly emerge to create what is being called a public health epidemic, clinicians are facing the great challenge of trying to provide optimal pain management for their patients while being mindful of the potential deleterious effects of the highly addictive opioids.
Heroin bill may give boost to providers treating substance abuseKentucky Senate Bill 192 may fund substance abuse providers to thwart heroin epidemic.
Opioid-dependent patients in ED need more than a treatment referralWhen addiction treatment was added to the buprenorphine Rx the result was greatly improved outcomes.
Actavis gains final FDA approval for generic SubutexActavis has received final approval from FDA on its Abbreviated New Drug Application for a generic version of Reckitt Benckiser's Subutex (buprenorphine 2 mg and 8 mg sublingual tablets) indicated for treatment of opioid dependence.